Prescription of fondaparinux in hospitalised patients

Thrombosis and Haemostasis

Volumn 101, Issue 6, 2009, Pages 1091-1094

  Baroletti, Steven ^a   Labreche, Matthew ^a   Niles, Matthew ^a   Fanikos, John ^a   Goldhaber, Samuel Z ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antithrombotic agents; Fondaparinux; Heparin induced thrombocytopenia

Indexed keywords

ARGATROBAN; ENOXAPARIN; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; FIBRINOLYTIC AGENT; POLYSACCHARIDE;

ADULT; AGED; ARTICLE; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG UTILIZATION; DRUG WITHDRAWAL; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OFF LABEL DRUG USE; PRIORITY JOURNAL; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED; HOSPITAL; MIDDLE AGED; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PRESCRIPTION; PULMONARY EMBOLISM; REGISTER; RISK FACTOR; THROMBOCYTOPENIA; TREATMENT OUTCOME; VENOUS THROMBOSIS;

ADULT; AGED; DRUG PRESCRIPTIONS; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HOSPITALS; HUMANS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; PERIOPERATIVE CARE; POLYSACCHARIDES; PULMONARY EMBOLISM; REGISTRIES; RISK FACTORS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 67049117568     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-01-0008     Document Type: Article

References (16)

1. Petitou M, Duchaussoy P, Herbert JM, et al. The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa. Semin Thromb Hemost 2002; 28: 393-402.a (Pubitemid 34971927)
2. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Ed.) Chest 2008: 454S-545S.
3. Buller HR, Davidson BL, Decousus H, et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349: 1695-1702. (Pubitemid 37315006)
4. Buller HR, Davidson BL, Decousus H, et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 2004; 140: 867-873. (Pubitemid 38685267)
5. The OASIS-5 Investigators. Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes: OASIS-5. N Engl J Med 2006; 354: 1464-1476.
6. Shetty R, Seddighzadeh A, Parasuraman S, et al. Once-daily fondaparinux monotherapy without warfarin for the treatment of venous thromboembolism. Thromb Heamost 2007; 98: 1384-1386. (Pubitemid 350239118)
7. Lobo B, Finch C, Howard A, et al. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia. Thromb Haemost 2008; 99: 208-214.
8. Gocke J. Lower extremity venous ultrasonography. In: Essentials of vascular laboratory diagnosis. Blackwell Publishing 2005; pp. 184-206.
9. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). J Am Med Assoc 1990; 263: 2753-2759.
10. Schoepf UJ, Goldhaber SZ, Costello P. Spiral computed tomography for acute pulmonary embolism. Circulation 2004; 109: 2160-2167. (Pubitemid 38625390)
11. Stein PD, Athanasoulis C, Alavi A, et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 1992; 85: 462-468.
12. Baroletti S, Piovella C, Labreche M, et al. Heparin Induced Thrombocytopenia (HIT): Clinical and Economic Outcomes. Thromb Haemost 2008; 100: 1130-1135.
13. Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med 2007; 356: 2653-2654. (Pubitemid 46961026)
14. Warkentin TE, Cook RJ, Marder VJ, et al. Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood 2005; 106: 3791-3796. (Pubitemid 41739014)
15. Rauova L, Poncz M, McKenzie SE, et al. Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia. Blood 2005; 105: 131-138. (Pubitemid 40053074)
16. Warkentin T. Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) - Bridging the River Coumarin. Thromb Haemost 2008; 99: 2-3.